Sodium (S)-2-(12-ethyl-8-(hydroxymethyl)-2-oxido-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoate
| Product Name |
Sodium (S)-2-(12-ethyl-8-(hydroxymethyl)-2-oxido-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoate
|
| Product Code |
DA-I045-z
|
| Chemical name |
Sodium (S)-2-(12-ethyl-8-(hydroxymethyl)-2-oxido-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoate
|
| Synonyms |
SN-38 Carboxylate Disodium Salt; Indolizino[1,2-b]quinoline-7-acetic acid, α,12-diethyl-9,11-dihydro-α,2-dihydroxy-8-(hydroxymethyl)-9-oxo-, (αS) Sodium; (αS)-α,12-Diethyl-9,11-dihydro-α,2-dihydroxy-8-(hydroxymethyl)-9-oxoindolizino[1,2-b]quinoline-7-acetic acid Disodium Salt;
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C22H20N2Na2O6
|
| Appearance |
Light Yellow to Dark Yellow Solid
|
| Melting Point |
NA
|
| Mol. Weight |
454.39
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
The active metabolite of Irinotecan (carboxylate form). SN-38 lactone and carboxylate may be considered pharmacokinetically distinct agents.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
